Pain and Fatigue Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00006253|
Recruitment Status : Completed
First Posted : March 8, 2004
Last Update Posted : December 7, 2011
Patients with advanced cancer who are undergoing chemotherapy and who report pain and fatigue at intake in the past 24 hours or at a level 2 or higher of pain or fatigue at a 3 or higher on a 10-point scale will be assigned randomly to an 8-week, 6-contact self management attention control (SMAC) intervention, or to a 8-week, 6-contact experimental patient intervention for management of symptoms and support (PIMSS) targeted toward symptom management, reducing impact on physical role and social functioning and emotional distress. Both groups will continue to receive conventional cancer care.
When compared with the self-management attention control intervention, patients exposed to the experimental intervention will report statistically significant positive effects on the following:
- The primary outcome--total number of symptoms reported;
- The secondary patient outcomes--reduced deterioration in physical role impact and social functioning, emotional distress, levels of communication with caregiver about care, and communication and satisfaction with provider care; and
- Caregiver outcomes--greater involvement in symptom management, increased mastery of the caregiving process, reduced levels of depression and burden.
|Condition or disease||Intervention/treatment||Phase|
|Carcinoma||Behavioral: Nurse Behavioral: Non-nurse coach||Not Applicable|
GOAL: The primary goal of this research is to test a symptom management intervention, delivered by nurses with special training, using a stepped-care approach targeted toward pain and fatigue, followed by fifteen other prevalent cancer symptoms. Second goals are to improve physical and social functioning, lower emotional distress, and improve communication with family caregiver in symptom management, and assist them to reduce their levels of depression and burden. This research is funded through a grant from the National Cancer Institutes, and builds upon the Family Care Research Team's program of supportive cancer-care research.
OUTCOMES: This study tests a stepped-approach intervention to determine if it improves symptom outcomes, especially pain and fatigue. Secondary outcomes addressed by the intervention are physical role impact, social functioning, and emotional distress. These outcomes can have significant impact on patients and family caregivers' well-being as patients undergo chemotherapy. The shorter, more intense intervention corresponds to changes int he clinical management of cancer patient with more intense, shorter chemotherapy treatments; therefore, this intervention will be more easily translatable to the clinical setting.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||350 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Family Home Care for Cancer - A Community-Based Model|
|Study Start Date :||March 2003|
|Actual Primary Completion Date :||October 2006|
|Actual Study Completion Date :||October 2006|
Receives symptom management assistance from an oncology nurse via the telephone
Receives 6 telephone calls over 8 weeks from an oncology nurse to assist with symptom management
Experimental: Non-nurse coach
Receives symptom management assistance from a non-nurse coach via telephone
Behavioral: Non-nurse coach
Receives 6 telephone calls over 8 weeks from a non-nurse coach to assist with symptom management
- Primary patient outcomeLower reported severity of symptoms
- Secondary Patient OutcomesReduced deterioration in physical role impact and social functioning, emotional distress, levels of communication with caregiver about care and communication, and satisfaction with provider care
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00006253
|United States, Michigan|
|Michigan State University|
|East Lansing, Michigan, United States, 48824|
|Study Chair:||Barbara A. Given, PhD, RN, FAAN||Breslin Cancer Center at Ingham Regional Medical Center|